BioSpace News Archive

Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, announced that Karen Zaderej, chairman, CEO, and president will present at the Canaccord Genuity 41st Annual Growth Conference.

Landos Biopharma, Inc. announced that data from the Phase 2 clinical trial of omilancor in ulcerative colitis has been accepted for oral presentation at the upcoming United European Gastroenterology Week 2021.

Plus Therapeutics, Inc., a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers, announced the first patient in the eighth cohort of the Phase 1 dose escalation ReSPECT™-GBM clinical trial for recurrent glioblastoma has been successfully treated.

Global Blood Therapeutics, Inc. announced updates across several of its development programs in sickle cell disease.

Arvinas, Inc. and Pfizer Inc. today announced a global collaboration to develop and commercialize ARV-471, an investigational oral PROTAC® (PROteolysis TArgeting Chimera) estrogen receptor protein degrader.

Oncolytics Biotech® Inc. announced that it will host a conference call and webcast on Friday, August 6, 2021, at 8:00 a.m. ET to discuss a corporate update and financial results for the second quarter 2021.

NuVasive, Inc. announced today the commercial launch of Modulus ® ALIF, a 3D-printed porous titanium implant for anterior lumbar interbody fusion (ALIF), in targeted global regions.

Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended June 30, 2021 after the market closes on Thursday, July 29, 2021 , and will host a conference call at 5:00 p.m. ET that day to discuss those results.

Tectonic Therapeutic today announced that Dr. Marcella (“Marcie”) Ruddy, MD has been appointed Chief Medical Officer.

Seres Therapeutics, Inc. today announced topline results from the Phase 2b ECO-RESET study evaluating SER-287 in patients with mild-to-moderate ulcerative colitis (UC).